Advances in the application of anti-inflammatory and liver-protecting drugs in treatment of autoimmune hepatitis
Autoimmune hepatitis (AIH) is the first liver disease which has proved responsive to glucocorticoids, and the standard therapeutic method is hormone combined with azathioprine. Given that some patients fail to reach the standard of immunosuppressive therapy, and the long-term use of immunosuppressiv...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2017-03-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8155 |
| Summary: | Autoimmune hepatitis (AIH) is the first liver disease which has proved responsive to glucocorticoids, and the standard therapeutic method is hormone combined with azathioprine. Given that some patients fail to reach the standard of immunosuppressive therapy, and the long-term use of immunosuppressive therapy has many adverse effects, it is necessary to reasonably use anti-inflammatory and liver-protecting drugs to minimize the dose of immunosuppressants, control liver inflammation, reduce the damage of liver cells, and delay the progression of the disease. This paper reviews the advances in the application of anti-inflammatory and liver-protecting drugs in the treatment of AIH, in order to help clinicians make rational decisions. |
|---|---|
| ISSN: | 1001-5256 1001-5256 |